WITHDRAWal of Heart Failure Pharmacotherapy in Patients with Normalized Left Ventricular Function After AF Rhythm Control in Arrhythmia Induced Cardiomyopathy-The WITHDRAW-AF Randomized Clinical Trial

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Doctor Louise Segan

The Alfred Hospital, Melbourne (Australia)

7 More presentations in this session

Presentation thumbnail

Thoracentesis to alleviate pleural effusion in acute heart failure: results from the pragmatic, multi-centre, open-label, randomised controlled TAP-IT trial

Doctor S. Glargaard (Copenhagen, DK)

Presentation thumbnail

Impact of a pneumococcal vaccination incentive campaign in chronic heart failure patients in France: a randomized clinical trial

Professor F. Roubille (Montpellier, FR)

Presentation thumbnail

Early in-hospital initiation of angiotensin-neprilysin inhibition in Japanese patients with acute heart failure: the investigator-initiated multicenter randomized PREMIER study

Professor A. Tanaka (Saga, JP)

Presentation thumbnail

Intensive therapeutic education strategy by specialised nurses for patients with acute Heart Failure: results from the multicentre randomized controlled EDUSTRA-HF trial.

Professor A. Cohen (Paris, FR)

Presentation thumbnail

Assessment of Digital consults in heart failure Management on clINical Impact, SafeTy and Efficiency using a RCT (ADMINISTER) trial

Assistant Professor M. Schuuring (Enschede, NL)

Access the full session

Session thumbnail

Smaller trials, trial updates, and other studies on heart failure (2)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources